These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9868353)

  • 21. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases.
    Christensen KR; Nairn AC
    Adv Pharmacol; 2021; 90():39-65. PubMed ID: 33706938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional plasticity in the organization of signaling complexes in the striatum.
    Allen PB
    Parkinsonism Relat Disord; 2004 Jul; 10(5):287-92. PubMed ID: 15196507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian function and morphology after deletion of the DARPP-32 gene in mice.
    Mayerhofer A; Fritz S; Mani S; Rajendra Kumar T; Thalhammer A; Ingrassia P; Fienberg AA; Greengard P
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):451-7. PubMed ID: 15372366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine.
    Snyder GL; Girault JA; Chen JY; Czernik AJ; Kebabian JW; Nathanson JA; Greengard P
    J Neurosci; 1992 Aug; 12(8):3071-83. PubMed ID: 1494946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.
    Hemmings HC; Greengard P; Tung HY; Cohen P
    Nature; 1984 Aug 9-15; 310(5977):503-5. PubMed ID: 6087160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of DARPP-32 in the actions of drugs of abuse.
    Nairn AC; Svenningsson P; Nishi A; Fisone G; Girault JA; Greengard P
    Neuropharmacology; 2004; 47 Suppl 1():14-23. PubMed ID: 15464122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background.
    Nally RE; Kinsella A; Tighe O; Croke DT; Fienberg AA; Greengard P; Waddington JL
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1281-7. PubMed ID: 15140917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice.
    Onn SP; Fienberg AA; Grace AA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):870-9. PubMed ID: 12805477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colocalization of dopamine receptor subtypes with dopamine and cAMP-regulated phosphoprotein (DARPP-32) in rat brain.
    Rajput PS; Kharmate G; Somvanshi RK; Kumar U
    Neurosci Res; 2009 Sep; 65(1):53-63. PubMed ID: 19465068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum.
    Liu FC; Graybiel AM
    Neuron; 1996 Dec; 17(6):1133-44. PubMed ID: 8982161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration.
    Greengard P; Nairn AC; Girault JA; Ouimet CC; Snyder GL; Fisone G; Allen PB; Fienberg A; Nishi A
    Brain Res Brain Res Rev; 1998 May; 26(2-3):274-84. PubMed ID: 9651542
    [No Abstract]   [Full Text] [Related]  

  • 32. Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin.
    Yan Z; Hsieh-Wilson L; Feng J; Tomizawa K; Allen PB; Fienberg AA; Nairn AC; Greengard P
    Nat Neurosci; 1999 Jan; 2(1):13-7. PubMed ID: 10195174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.
    Bálint E; Kitka T; Zachar G; Adám A; Hemmings HC; Csillag A
    J Chem Neuroanat; 2004 Sep; 28(1-2):27-36. PubMed ID: 15363488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine in the developing kidney.
    Svennilson J; Aperia A
    Int J Dev Biol; 1999; 43(5):441-3. PubMed ID: 10535321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.
    Greengard P; Allen PB; Nairn AC
    Neuron; 1999 Jul; 23(3):435-47. PubMed ID: 10433257
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
    Bibb JA; Yan Z; Svenningsson P; Snyder GL; Pieribone VA; Horiuchi A; Nairn AC; Messer A; Greengard P
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6809-14. PubMed ID: 10829080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells.
    Aperia A; Fryckstedt J; Svensson L; Hemmings HC; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2798-801. PubMed ID: 1849276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroscience. A kinase to dampen the effects of cocaine?
    Gupta A; Tsai LH
    Science; 2001 Apr; 292(5515):236-7. PubMed ID: 11305318
    [No Abstract]   [Full Text] [Related]  

  • 39. The significance of L-amino acid decarboxylase and DARPP-32 in the kidney.
    Aperia A; Hökfelt T; Meister B; Bertorello A; Fryckstedt J; Holtbäck U; Seri I
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):11S-13S. PubMed ID: 2166532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DARPP-32: molecular integration of phosphorylation potential.
    Le Novère N; Li L; Girault JA
    Cell Mol Life Sci; 2008 Jul; 65(14):2125-7. PubMed ID: 18488140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.